SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Exclusive interview

CDMOs: Leave aseptic manufacturing to the Vetters of this world, says Aesica

14-Oct-2014 - Aesica has turned its back on sterile injectables manufacturing and, in an exclusive interview, told Outsourcing-Pharma.com there is now limited steriles capability in the UK following the exit of other key players. 

Catalent calls for greater academic and industry collaboration on delivery tech

02-Oct-2014 - Catalent has urged industry and academia to share knowledge about delivery technologies to help improve drug efficacy as it signs a deal to develop ADHD treatments for Cingulate.

dispatches from technopharm

Personalised meds to deliver bigger market for oral film technologies says expert

02-Oct-2014 - Flexible inkjet printing and personalized medicine will grow the market for orodispersible delivery technologies according to experts at a conference in Germany this week.

Acorda gains pulmonary drug delivery tech in $525 Civitas deal

25-Sep-2014 - Acorda has gained a pulmonary delivery technology and a GMP manufacturing site in Massachusetts along with a Parkinson’s disease candidate in its $525m (€410m) acquisition of Civitas.

Telormedix granted 'most important patent ' for TLR agonist bladder cancer drug

22-Sep-2014 - Telormedix has been granted a European patent for increasing the solubility of its lead bladder cancer toll-like receptors (TLR) treatment Vesimune.

Feature

Nobel prizes and the world’s top drug: a gallery of Scottish pharma

17-Sep-2014 - On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a look at the pharma inventions Scotland gave the world.

Galen plans to sell “green whistle” inhalable pain drug in UK and Ireland

16-Sep-2014 - Almac’s subsidiary Galen has licensed UK sales and marketing rights to an emergency pain drug nicknamed the “green whistle” from Australian firm Medical Developments International (MVP).

Unilife accelerates expansion to fulfill demand for delivery devices

15-Sep-2014 - Unilife has invested in manufacturing capacity for its drug delivery devices ahead of schedule to support the accelerated commercial launch date of its customers' products.

Singapore researchers develop microneedle patch to better deliver pain meds

15-Sep-2014 - Researchers from the National University of Singapore (NUS) have developed a microneedle patch that can deliver lidocaine in what they say is a “faster, more effective and painless” way.

News in brief

Cipla buys Indian plants from contractor

11-Sep-2014 - Indian drugmaker Cipla has bought two manufacturing facilities from its contractor Okasa Pharma.

Natoli opens R&D site to study tablet formulation problems

10-Sep-2014 - The Natoli Engineering Company has opened an pharmaceutical research institute to look for answers to enduring formulation problems in solid oral dosage.

Seaweed: the secret ingredient to HIV drug delivery?

09-Sep-2014 - Food scientists may have hit on a novel delivery method for HIV antiretrovirals: a vaginal suppository made with seaweed.

Meda sells NJ facility to DPT; outsources intra-urethral ED drug

04-Sep-2014 - Meda has sold a New Jersey facility dedicated to its intra-urethral erectile dysfunction drug Muse as part of a strategic review of its manufacturing network.

‘James bond’-like tech is the end to overdoses, says formulation firm

03-Sep-2014 - Canadian drugmaker Intellipharmaceutics has developed a kill-switch formulation it says will prevent drug misuse and accidental overdoses.

Find other oral forms for tablet-hating patients, drugmakers told

02-Sep-2014 - Pharma firms must provide imaginative solid dosage alternatives to tablets and capsules, says research claiming more than half of patients have problems swallowing traditional pills.

CFDA approves BTG bead delivery device for liver cancer

29-Aug-2014 - BTG has received approval from the China FDA for a liver cancer treatment which uses its hydrogel product DC Beads.

GSK and Immunovaccine: delivery techs promise to deliver Ebola vaccine

29-Aug-2014 - A candidate Ebola vaccine that uses Immunovaccine's formulation technology has stopped cynomolgus monkeys from catching the disease in a preclinical study.

GSK welcomes US OK for Arnuity in light of declining Advair sales

21-Aug-2014 - US FDA approval of the inhaled corticosteroid (ICS) asthma drug Arnuity will help offset declining sales of the off-patent bestseller Advair, says GlaxoSmithKline.

US FDA approves first needle-free flu vaccine delivery system

19-Aug-2014 - For the first time ever, the US FDA has approved a needle-free injection system to deliver the seasonal flu vaccine.

Prometheon goes crowdfunding to develop patch delivery tech

12-Aug-2014 - Pricks are a problem for the drug industry according to Prometheon Pharma, which has launched a crowdfunding campaign to help it develop a needle-free alternative delivery tech.

Roche's oral octreotide pull-out no risk for Capsugel, says Chiasma

12-Aug-2014 - Chiasma says a scale-up manufacturing agreement with Capsugel will be unaffected despite Roche pulling out of a commercialisation contract for its oral peptide drug octreotide acetate.

Sanofi in $150m deal to commercialise Mannkind's inhaled insulin

11-Aug-2014 - Mannkind has partnered Sanofi for the marketing and commercialisation of its inhaled insulin drug Afrezza, recently approved by the US FDA.

Oncologist: Delivery is key for improving pancreatic cancer treatment

06-Aug-2014 - Pancreatic cancer is notoriously difficult to treat.  One problem is drug delivery, because pancreatic cells can cluster in a nest of scar-like tissue. 

Actavis welcomes AZ in boosting its LAMA/LABA

06-Aug-2014 - Actavis says it is excited to partner with AstraZeneca over its long-acting muscarinic antagonist/beta-agonist (LAMA/LABA) fixed dose combination respiratory drug following the latter’s acquisition of Almirall.

Roche re-enters gene silencing space with $250m LNA acquisition

05-Aug-2014 - Roche has renewed its interest in gene silencing drugs, paying $250m (€187m) for Santaris Pharma including its ‘antisense’ Locked Nucleic Acid (LNA) platform.

Spotlight

Share API audits or see quality slump, says Hovione

Share API audits or see quality slump, says Hovione

The sharing of audit reports for active pharmaceutical ingredients (APIs) is essential in order to help avert...

Personalised meds to deliver bigger market for oral film technologies says expert
dispatches from technopharm

Personalised meds to deliver bigger market for oral film technologies says expert

Flexible inkjet printing and personalized medicine will grow the market for orodispersible delivery technologies according to experts...

Complex regs and unknown markets top API shippers' logistics headaches
Pre CPhI Special

Complex regs and unknown markets top API shippers' logistics headaches

The world is getting larger, at least it is in terms of the pharmaceutical industry, according to...

How green was my Valium? Not very, despite industry claims
Pre CPhI Special

How green was my Valium? Not very, despite industry claims

Making active pharmaceutical ingredients (API) is a dirty business and you’d have to be pretty green to...

WHO welcomes industry response to Ebola crisis but calls for new drugs

WHO welcomes industry response to Ebola crisis but calls for new drugs

The Pharma industry has responded to the Ebola crisis in West Africa with developmental vaccines and aid...

Say ‘cheese’: database collects pill photos

Say ‘cheese’: database collects pill photos

The US National Institutes of Health (NIH) is collecting photos of pills and tablet in a database...

Key Industry Events

 

Access all events listing

Our events, Events from partners...